Genecast Information

At Genecast, we advance precision oncology through integrated molecular diagnostics, translational research, and scientific innovation. Genecast supports precision oncology across early detection, genomic profiling, therapy selection, molecular residual disease (MRD) monitoring, and recurrence surveillance. Through targeted NGS, liquid biopsy, multiplex PCR, and multi-omics capabilities, we deliver clinically meaningful insights that support more informed and personalized cancer care. Headquartered in Asia, Genecast brings together clinical laboratory expertise, scientific capabilities, and scalable diagnostic infrastructure to support the advancement of precision medicine across the region. Our laboratories and solutions are supported by internationally recognized quality and accreditation standards, including CAP, CLIA, ISO15189, CE-IVD, and NMPA certifications. Beyond our laboratory operations, Genecast has an expanding regional presence across Singapore, China, Southeast Asia, and the Middle East through collaborations with hospitals, cancer centers, clinicians, academic institutions, and healthcare partners. We actively support translational research, scientific collaboration, and the broader adoption of precision oncology approaches within Asian populations. Our integrated precision oncology portfolio supports the cancer care continuum through molecular diagnostics spanning therapy selection, disease monitoring, recurrence surveillance, and multi-cancer early detection. At Genecast, we believe precision diagnostics should not only support treatment decisions, but also contribute to the future of cancer research, early detection, and personalized medicine.